-
Loading metrics
Open Access
Peer-reviewed
Research Article
DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer
-
Steven T. Lott,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Nanyue Chen,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Dawn S. Chandler,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Qifeng Yang,
Affiliation Department of Radiation Oncology, University of Medicine & Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
⨯ -
Luo Wang,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Marivonne Rodriguez,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Hongyan Xie,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Seetharaman Balasenthil,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Thomas A. Buchholz,
Affiliation Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Aysegul A. Sahin,
Affiliation Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Katrina Chaung,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Baili Zhang,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Shodimu-Emmanu Olufemi,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Jinyun Chen,
Affiliation Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Henry Adams,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Vimla Band,
Affiliation Department of Genetics, Cell Biology and Anatomy, The University of Nebraska Medical Center, Eppley Cancer Center, Omaha, Nebraska, United States of America
⨯ -
Adel K. El-Naggar,
Affiliation Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Marsha L. Frazier,
Affiliation Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Khandan Keyomarsi,
Affiliation Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Kelly K. Hunt,
Affiliation Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Subrata Sen,
Affiliation Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Bruce Haffty,
Affiliation Department of Radiation Oncology, University of Medicine & Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
⨯ -
Stephen M. Hewitt,
Affiliation Tissue Array Research Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Ralf Krahe,
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ - [ ... ],
-
Ann McNeill Killary
* E-mail: akillary@mdanderson.org
Affiliation Department of Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America
⨯ - [ view all ]
- [ view less ]
DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer
- Steven T. Lott,
- Nanyue Chen,
- Dawn S. Chandler,
- Qifeng Yang,
- Luo Wang,
- Marivonne Rodriguez,
- Hongyan Xie,
- Seetharaman Balasenthil,
- Thomas A. Buchholz,
- Aysegul A. Sahin
- Published: May 5, 2009
- https://doi.org/10.1371/journal.pmed.1000068